Fifty children with malignant diseases were vaccinated against hepatitis B. Twenty-nine children suffered from leukaemia or non-Hodgkin's lymphoma; 14 of these were on intensive chemotherapy (group I) and 15 were without intensive therapy (group II). The other 21 children had various forms of solid
Duration of hepatitis B antibody response in children immunised with hepatitis B and compulsory vaccines
β Scribed by S. Li Volti; G. Giammanco-Bilancia; G. Giammanco; F. Mollica
- Publisher
- Springer
- Year
- 1995
- Tongue
- English
- Weight
- 338 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0393-2990
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Hepatitis B (HB) vaccine provides an uncertain duration of protection and the optimal timing of booster vaccine remains unclear. This study examined the immune response at 10 years of 118 children who had developed protective anti-HB surface (anti-HBs) levels after a primary series of HB immunizatio
Abbreviations: HBsAg, hepatitis B surface antigen; anti-HBs, hepatitis B surface antimonths. 2 From the 415 children, we recruited 16 chronically infected gen antibody; HBV, hepatitis B virus; PCR, polymerase chain reaction; PBMC, peripheral children who had cleared serum HBsAg for more than 2 years
## Abstract The kinetics of antibody response to the group determinant __a__ and subdeterminants __d__ and __y__ of hepatitis B virus were studied after infection and following immunisation with two recombinant DNA yeastβderived hepatitis B vaccines. The initial antibody response was to the subdete
Data regarding the outcome of children with chronic hepatitis B after seroconversion are scarce. We describe the long-term evolution of these patients. One hundred and three children with antibody against hepatitis B e antigen and normal alanine aminotransferase (ALT) levels were followed for 0.6 to